【摘要】目的：探讨分析吉西他滨联合顺铂治疗中晚期肺癌的临床疗效。方法：回顾性分析于2021年1月—2023年1月期间在本医院使用吉西他滨联合顺铂进行抗肿瘤治疗的15例中晚期肺癌患者，比较治疗前后的生活质量评测值、治疗效果相关数据、不良反应发生情况。结果：治疗举措实施后，得出患者治疗后的疗效率较高，总治疗效果例数为12例，总疗效率80.00%，其完全缓解、部分缓解、稳定、进展对应例数分别为4例(33.33.00%)、6例(50.00%)、3例(25.00%)、2例(16.67%)。得出药物的不良反应发生率较低，总发生例数为2例，发生率为16.67%，主要副反应为白细胞减少、胃肠道反应对应例数均为1例(8.33%)、1例(8.33%)。结论：吉西他滨联合顺铂治疗方案，对中晚期肺癌患者，能提升患者的生活质量，得到较好的治疗效果，且不良反应发生率较低，应用价值突出。

    【关键词】吉西他滨；顺铂；中晚期肺癌；临床疗效

    Clinical efficacy of gemcitabine combined with cisplatin in the treatment of advanced lung cancer

    CHEN Ling

    Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University)， Changsha， Hunan 410000， China

    【Abstract】Objective： To investigate the clinical effica cy of gemcitabine combined with cisplatin in the treatment of advanced lung cancer. Methods： Fifteen patients with advanced lung cancer who received anti-tumor therapy with gemcitabine combined with cisplatin in our hospital from January 2021 to January 2023 were retrospectively analyzed， and the quality of life evaluation values， the relevant data of treatment effect and the occurrence of adverse reactions before and after treatment were compared. Results： After the implementation of treatment measures ......